Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.55
+0.01 (+1.85%)
(As of 11/1/2024 ET)

PETV vs. APYX, CODX, STIM, SURG, FEMY, DRIO, OM, MDAI, IRIX, and XAIR

Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Apyx Medical (APYX), Co-Diagnostics (CODX), Neuronetics (STIM), SurgePays (SURG), Femasys (FEMY), DarioHealth (DRIO), Outset Medical (OM), Spectral AI (MDAI), IRIDEX (IRIX), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry.

PetVivo vs.

Apyx Medical (NASDAQ:APYX) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, community ranking, profitability, risk, analyst recommendations, dividends and media sentiment.

Apyx Medical has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.46, indicating that its share price is 146% more volatile than the S&P 500.

PetVivo has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$52.35M0.79-$18.71M-$0.82-1.45
PetVivo$970K11.55-$10.95M-$0.65-0.85

In the previous week, Apyx Medical had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for Apyx Medical and 0 mentions for PetVivo. Apyx Medical's average media sentiment score of 1.31 beat PetVivo's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media.

Company Overall Sentiment
Apyx Medical Positive
PetVivo Neutral

Apyx Medical currently has a consensus price target of $5.00, indicating a potential upside of 320.17%. Given Apyx Medical's higher probable upside, research analysts clearly believe Apyx Medical is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Apyx Medical received 78 more outperform votes than PetVivo when rated by MarketBeat users.

CompanyUnderperformOutperform
Apyx MedicalOutperform Votes
78
60.94%
Underperform Votes
50
39.06%
PetVivoN/AN/A

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 24.6% of PetVivo shares are held by institutional investors. 16.8% of Apyx Medical shares are held by insiders. Comparatively, 20.1% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Apyx Medical has a net margin of -57.86% compared to PetVivo's net margin of -1,036.82%. Apyx Medical's return on equity of -105.45% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-57.86% -105.45% -36.80%
PetVivo -1,036.82%-1,038.50%-266.37%

Summary

Apyx Medical beats PetVivo on 11 of the 17 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$11.21M$4.45B$5.40B$8.53B
Dividend YieldN/A42.37%5.15%4.14%
P/E Ratio-0.8536.56112.5515.07
Price / Sales11.5564.751,478.8293.55
Price / CashN/A49.2739.8334.04
Price / Book7.864.214.645.01
Net Income-$10.95M$11.52M$119.13M$225.46M
7 Day Performance9.76%1.05%0.78%0.37%
1 Month Performance19.54%0.94%5.65%3.57%
1 Year Performance-63.65%39.40%36.90%29.42%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.55
+1.9%
N/A-61.3%$11.21M$970,000.00-0.8520Gap Up
High Trading Volume
APYX
Apyx Medical
4.4991 of 5 stars
$1.23
-1.6%
$5.00
+306.5%
-49.1%$42.61M$49.03M-1.50270Upcoming Earnings
Positive News
Gap Up
CODX
Co-Diagnostics
3.2307 of 5 stars
$1.22
+0.8%
$1.50
+23.0%
+13.1%$38.93M$9.14M-0.97100Upcoming Earnings
Short Interest ↑
STIM
Neuronetics
2.5974 of 5 stars
$1.07
+5.9%
$4.67
+336.1%
-10.4%$32.10M$72.07M-0.96180Upcoming Earnings
News Coverage
SURG
SurgePays
3.6214 of 5 stars
$1.54
-11.5%
$9.00
+486.3%
-64.2%$30.32M$137.14M17.0622News Coverage
FEMY
Femasys
3.4353 of 5 stars
$1.36
-1.4%
$10.67
+684.3%
-9.4%$30.24M$950,096.00-1.6430Analyst Forecast
News Coverage
High Trading Volume
DRIO
DarioHealth
2.1152 of 5 stars
$1.00
+5.3%
$4.00
+300.8%
-6.2%$29.86M$19.15M-0.85200Upcoming Earnings
OM
Outset Medical
2.2769 of 5 stars
$0.54
-1.8%
$4.70
+770.5%
-83.8%$28.12M$116.43M-0.17520Upcoming Earnings
MDAI
Spectral AI
2.3991 of 5 stars
$1.56
+8.3%
$4.50
+188.5%
-51.5%$27.27M$22.53M-1.1678Upcoming Earnings
Gap Down
IRIX
IRIDEX
1.0829 of 5 stars
$1.60
-0.6%
$2.00
+25.0%
-30.1%$26.01M$49.70M-2.42120Analyst Forecast
Short Interest ↑
Gap Up
XAIR
Beyond Air
4.5283 of 5 stars
$0.52
+8.3%
$3.67
+606.2%
-79.0%$24.15M$1.78M-0.3270Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners